CLIN CANCER RES:BMP4诱导M2巨噬细胞极化促进膀胱癌进展

2017-12-10 MedSci MedSci原创

膀胱癌目前是一道临床难题,也是社会性难题。诊断时,大部分病人表现为非肌层浸润肿瘤,复发率高,可以进展为肌层浸润肿瘤并转移。膀胱组织中的骨形成蛋白(BMP)依赖信号通路可以促进尿路上皮细胞分化调节尿路上皮稳态。但是BMP配体在膀胱癌中的作用尚不清楚。CLIN CANCER RES近期发表了一篇文章研究这一问题。

膀胱癌目前是一道临床难题,也是社会性难题。诊断时,大部分病人表现为非肌层浸润肿瘤,复发率高,可以进展为肌层浸润肿瘤并转移。膀胱组织中的骨形成蛋白(BMP)依赖信号通路可以促进尿路上皮细胞分化调节尿路上皮稳态。但是BMP配体在膀胱癌中的作用尚不清楚。CLIN CANCER RES近期发表了一篇文章研究这一问题。

作者分析了68例尿路上皮癌组织和正常组织,分析BMP表达和巨噬细胞标志。在体外实验中通过膀胱癌细胞系和外周血巨噬细胞研究其机制。研究结果发现,BMP4表达与Ⅱ型巨噬细胞分化有关。体外实验表明含有BMP4的培养基中膀胱癌细胞系更倾向于向M2亚型巨噬细胞分化,通过IL10分泌和表达可以观察到。通过一系列膀胱癌标本,作者发现在晚期及未分化的肿瘤中BMP4表达升高且与上皮间质化(EMT)密切相关。肿瘤组织pSmad1,5,8染色表明EMT信号减弱,原因是miR-21表达增加导致BMPR2表达降低。

文章最后认为,膀胱癌细胞BMP4分泌为肿瘤免疫微环境提供了必须的M2信号。此外,miR-21导致的BMPR2下降使得肿瘤细胞分化程度降低,有助于肿瘤生长。

原始出处:
Victor G.Martinez,Carolina Rubio,et al.BMP4 Induces M2 Macrophage Polarization and Favors Tumor Progression in Bladder Cancer.CLIN CANCER RES.December 2017 doi:10.1158/1078-0432.CCR-17-1004

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1634015, encodeId=d65316340155b, content=<a href='/topic/show?id=596635e549' target=_blank style='color:#2F92EE;'>#BMP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3575, encryptionId=596635e549, topicName=BMP)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d95322064897, createdName=HNYYM, createdTime=Tue Jun 26 16:09:00 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597875, encodeId=909b159e87516, content=<a href='/topic/show?id=b1e3e7926ba' target=_blank style='color:#2F92EE;'>#细胞极化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77926, encryptionId=b1e3e7926ba, topicName=细胞极化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e318558301, createdName=tastas, createdTime=Tue Dec 12 01:09:00 CST 2017, time=2017-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602776, encodeId=e6e21602e7689, content=<a href='/topic/show?id=c41c11192e2' target=_blank style='color:#2F92EE;'>#M2巨噬细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11192, encryptionId=c41c11192e2, topicName=M2巨噬细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3718929485, createdName=马龙, createdTime=Tue Dec 12 01:09:00 CST 2017, time=2017-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=268373, encodeId=c7fb2683e320, content=学习了.值得分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun Dec 10 13:23:26 CST 2017, time=2017-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=268344, encodeId=3a94268344dd, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Sun Dec 10 10:40:36 CST 2017, time=2017-12-10, status=1, ipAttribution=)]
    2018-06-26 HNYYM
  2. [GetPortalCommentsPageByObjectIdResponse(id=1634015, encodeId=d65316340155b, content=<a href='/topic/show?id=596635e549' target=_blank style='color:#2F92EE;'>#BMP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3575, encryptionId=596635e549, topicName=BMP)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d95322064897, createdName=HNYYM, createdTime=Tue Jun 26 16:09:00 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597875, encodeId=909b159e87516, content=<a href='/topic/show?id=b1e3e7926ba' target=_blank style='color:#2F92EE;'>#细胞极化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77926, encryptionId=b1e3e7926ba, topicName=细胞极化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e318558301, createdName=tastas, createdTime=Tue Dec 12 01:09:00 CST 2017, time=2017-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602776, encodeId=e6e21602e7689, content=<a href='/topic/show?id=c41c11192e2' target=_blank style='color:#2F92EE;'>#M2巨噬细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11192, encryptionId=c41c11192e2, topicName=M2巨噬细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3718929485, createdName=马龙, createdTime=Tue Dec 12 01:09:00 CST 2017, time=2017-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=268373, encodeId=c7fb2683e320, content=学习了.值得分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun Dec 10 13:23:26 CST 2017, time=2017-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=268344, encodeId=3a94268344dd, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Sun Dec 10 10:40:36 CST 2017, time=2017-12-10, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1634015, encodeId=d65316340155b, content=<a href='/topic/show?id=596635e549' target=_blank style='color:#2F92EE;'>#BMP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3575, encryptionId=596635e549, topicName=BMP)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d95322064897, createdName=HNYYM, createdTime=Tue Jun 26 16:09:00 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597875, encodeId=909b159e87516, content=<a href='/topic/show?id=b1e3e7926ba' target=_blank style='color:#2F92EE;'>#细胞极化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77926, encryptionId=b1e3e7926ba, topicName=细胞极化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e318558301, createdName=tastas, createdTime=Tue Dec 12 01:09:00 CST 2017, time=2017-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602776, encodeId=e6e21602e7689, content=<a href='/topic/show?id=c41c11192e2' target=_blank style='color:#2F92EE;'>#M2巨噬细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11192, encryptionId=c41c11192e2, topicName=M2巨噬细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3718929485, createdName=马龙, createdTime=Tue Dec 12 01:09:00 CST 2017, time=2017-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=268373, encodeId=c7fb2683e320, content=学习了.值得分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun Dec 10 13:23:26 CST 2017, time=2017-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=268344, encodeId=3a94268344dd, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Sun Dec 10 10:40:36 CST 2017, time=2017-12-10, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1634015, encodeId=d65316340155b, content=<a href='/topic/show?id=596635e549' target=_blank style='color:#2F92EE;'>#BMP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3575, encryptionId=596635e549, topicName=BMP)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d95322064897, createdName=HNYYM, createdTime=Tue Jun 26 16:09:00 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597875, encodeId=909b159e87516, content=<a href='/topic/show?id=b1e3e7926ba' target=_blank style='color:#2F92EE;'>#细胞极化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77926, encryptionId=b1e3e7926ba, topicName=细胞极化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e318558301, createdName=tastas, createdTime=Tue Dec 12 01:09:00 CST 2017, time=2017-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602776, encodeId=e6e21602e7689, content=<a href='/topic/show?id=c41c11192e2' target=_blank style='color:#2F92EE;'>#M2巨噬细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11192, encryptionId=c41c11192e2, topicName=M2巨噬细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3718929485, createdName=马龙, createdTime=Tue Dec 12 01:09:00 CST 2017, time=2017-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=268373, encodeId=c7fb2683e320, content=学习了.值得分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun Dec 10 13:23:26 CST 2017, time=2017-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=268344, encodeId=3a94268344dd, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Sun Dec 10 10:40:36 CST 2017, time=2017-12-10, status=1, ipAttribution=)]
    2017-12-10 1ddf0692m34(暂无匿称)

    学习了.值得分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1634015, encodeId=d65316340155b, content=<a href='/topic/show?id=596635e549' target=_blank style='color:#2F92EE;'>#BMP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3575, encryptionId=596635e549, topicName=BMP)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d95322064897, createdName=HNYYM, createdTime=Tue Jun 26 16:09:00 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597875, encodeId=909b159e87516, content=<a href='/topic/show?id=b1e3e7926ba' target=_blank style='color:#2F92EE;'>#细胞极化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77926, encryptionId=b1e3e7926ba, topicName=细胞极化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e318558301, createdName=tastas, createdTime=Tue Dec 12 01:09:00 CST 2017, time=2017-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602776, encodeId=e6e21602e7689, content=<a href='/topic/show?id=c41c11192e2' target=_blank style='color:#2F92EE;'>#M2巨噬细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11192, encryptionId=c41c11192e2, topicName=M2巨噬细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3718929485, createdName=马龙, createdTime=Tue Dec 12 01:09:00 CST 2017, time=2017-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=268373, encodeId=c7fb2683e320, content=学习了.值得分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun Dec 10 13:23:26 CST 2017, time=2017-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=268344, encodeId=3a94268344dd, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Sun Dec 10 10:40:36 CST 2017, time=2017-12-10, status=1, ipAttribution=)]
    2017-12-10 1e0f8808m18(暂无匿称)

    学习了.谢谢分享.

    0

相关资讯

JAMA SURGERY:新辅助化疗联合放疗与单纯新辅助化疗对比治疗局部晚期膀胱癌

局部晚期膀胱癌根治性切除后局部治疗失败常见,与患者发病率和死亡率增高有关。新辅助放疗可以减少局部治疗失败可能,但尚未在化疗领域进行研究。JAMA SURGERY近期发表了一篇文章,研究放疗联合化疗与新辅助化疗相比是否可以改善患者局部无复发生存情况。

J Urol:一种检测膀胱癌的灵敏度比尿细胞学更高的90分钟一体化尿液分析方法。

尽管敏感性不佳,但尿细胞学通常作为膀胱镜检查诊断膀胱癌的辅助手段。本研究的目标是开发一种非侵入性,快速检测膀胱癌的分子诊断测试,它比尿细胞学检测的灵敏度更高,同时又能够保持足够的特异性。

晚期膀胱癌5年生存率不足5%,肿瘤免疫治疗或带来希望

据估计,膀胱癌已经占到我国泌尿系肿瘤发病率的第一位,大约10%的膀胱癌患者在诊断时就已经是晚期,且膀胱癌患者通常预后较差,晚期患者的5年生存率不足5%。中国膀胱癌联盟主席、中华医学会泌尿外科分会候任主任委员、中山大学孙逸仙纪念医院黄健教授指出,我国膀胱癌现有的治疗方案主要以化疗为主,但是疗效有限,长期使用容易产生耐药,加上严重的副反应极大地影响患者的生活质量,而且预后仍然不够理想。“有50%的患者

CLIN CANCER RES:放射性诺模图术前预测膀胱癌淋巴结转移

CLIN CANCER RES近期发表了一篇文章,研究放射性诺模图在膀胱癌淋巴结转移术前诊断中的应用。

Cell Mol Life Sci:蛋白激酶D抑制剂CRT0066101通过在G2 / M阻断细胞周期抑制膀胱癌细胞体外和异种移植物的生长。

在本研究中,作者发现CRT0066101在体外抑制了四种膀胱癌细胞系的增殖和迁移,并且证明CRT0066101能够阻断膀胱癌小鼠侧腹异种移植模型中肿瘤的生长。

CLIN CANCER RES:PI3K通路作为膀胱癌的潜在治疗靶点

超过40%的膀胱尿路上皮癌中出现PI3K通路激活。CLIN CANCER RES近期发表了一篇文章,研究靶向PI3K通路药物的治疗潜力及耐药机制。